School of Medicine

Washington University in St. Louis has been recognized as a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.

Donald “Don” E. Clayton, a former associate vice chancellor of Medical Public Affairs at WashU Medicine, died Jan. 8 after a respiratory illness. He was 71.

In a new study, WashU Medicine researchers show that vagus nerve stimulation provides substantial, long-lasting relief to some people with the most severe treatment-resistant depression.

A team of WashU researchers has integrated two novel vision-language models that create a potential AI assistant that may help people with cognitive decline cook meals and remain independent.

Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the bone marrow. The new resource could improve prognosis and guide development of new immunotherapies.

Startups built on WashU discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices.

Steven L. Teitelbaum, MD, a nationally recognized leader in bone biology research at WashU Medicine, died Dec. 15 in St. Louis. He was 87.

In a new study, WashU Medicine researchers found that widely prescribed drugs such as Ritalin and Adderall don’t affect attention-controlling regions of the brain, as previously thought, but rather act on areas involved in wakefulness and reward.

Long-term use of a new drug, toferson, approved by the FDA for a rare genetic form of ALS, delays symptom progression and death and leads to stabilization or improvement in some patients, according to a study by WashU Medicine researchers and collaborators.

Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor and head of the WashU Medicine Department of Biochemistry and Molecular Biophysics, has received the American Chemical Society’s 2025 Saint Louis Section Award.